Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the safety and efficacy of varying doses of ISIS 301012 as
add-on therapy in subjects with Homozygous Familial Hypercholesterolemia